X4 Pharmaceuticals Inc (XFOR)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -268.786 | -76.349 | -73.378 | -54.294 | -43.821 | -85.516 | -70.694 | -66.811 |
Return on Equity (%) | 50.614 | -3162.797 | -107.141 | -70.812 | -61.51 | -149.608 | -139.262 | -161.673 |
Return on Invested Capital (%) | 62.598 | -370.177 | -95.414 | -54.863 | -49.982 | -82.876 | -91.659 | -102.793 |
Operating Margin (%) | N/A | N/A | -1199.486 | N/A | -1976.5 | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | -1229.171 | N/A | -2071.033 | N/A | N/A | N/A |
Book Value Per Share | -110.043 | 4.107 | 1.482 | 6.331 | 2.802 | 1.673 | 0.466 | 0.202 |
Earnings Per Share | -44.747 | -2.373 | -2.952 | -3.311 | -3.81 | -3.649 | -0.792 | -0.605 |
Cash Per Share | 5.905 | 5.372 | 2.11 | 7.823 | 4.827 | 2.908 | 1 | 0.593 |
Working Capital Per Share | -12.342 | 4.817 | 2.037 | 7.43 | 4.376 | 2.626 | 0.874 | 0.593 |
Operating Profit Per Share | N/A | N/A | 0.24 | N/A | 0.184 | N/A | N/A | N/A |
EBIT Per Share | -44.698 | -2.37 | -2.952 | -3.274 | -3.801 | -3.153 | -0.771 | -0.604 |
EBITDA Per Share | -44.698 | -2.37 | -2.952 | -3.274 | -3.801 | -3.153 | -0.771 | -0.604 |
Free Cash Flow Per Share | -45.16 | -2.384 | -2.961 | -3.306 | -3.748 | -3.645 | -0.796 | -0.607 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 514k | 14,29M | 14,57M | 16,13M | 16,31M | 28,13M | 121,67M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 68,74M | 121,67M | 122,21M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 104,05M |
Ratio cours/bénéfice | -1,07 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,09 |
Ratio prix/valeur comptable | 2,11 |
Rendement de dividende | - |
Actions en circulation | 168,5M |
Volume moyen (1 semaine) | 1,42M |
Volume moyen (1 mois) | 1,31M |
Variation sur 52 semaines | -13,56% |
Plus haut sur 52 semaines | 1,60 |
Plus bas sur 52 semaines | 0,4721 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales